Hiram S. Cody - Concepedia

Author

Hiram S. Cody

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

H Cody, H S Cody, H S Cody III, H. Cody, H. S. Cody, H. S. Cody III, H.S. Cody, H.S. Cody III, HIRAM S. CODY, Hiram Cody

251

Publications

15.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University

About

Hiram S. Cody is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	62	6.5K
2	Health Sciences	18	21	2.4K
3	Engineering	2	2	397
4	Nursing	1	1	25
5	Public Health	1	1	104

Hiram S. Cody

108

Publications

13.7K

Citations

H-Index

Page 1

	Year	Citations
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Gary H. Lyman, Armando E. Giuliano, Mark R. Somerfield, Journal of Clinical Oncology	2005	1.9K
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Gary H. Lyman, Sarah Temin, Stephen B. Edge, Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementPathologyAmerican Society	2014	1K
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy Kimberly J. Van Zee, Donna-Marie E. Manasseh, J.L.B. Bevilacqua, Annals of Surgical Oncology Breast OncologyCancer DetectionBreast Cancer PatientsAdditional Nodal MetastasesMedicine	2003	818
Is Breast Cancer the Same Disease in Asian and Western Countries? Stanley P. L. Leong, Zhen‐Zhou Shen, Tse‐Jia Liu, World Journal of Surgery	2010	635
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection Arpana Naik, Jane V. Fey, Mary L. Gemignani, Annals of Surgery	2004	400
Lessons Learned From 500 Cases of Lymphatic Mapping for Breast Cancer Arnold Hill, Katherine N. Tran, Tim Akhurst, Annals of Surgery	1999	363
Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation José Luiz Barbosa Bevilacqua, Michael W. Kattan, Jane V. Fey, Journal of Clinical Oncology	2007	343
Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion? Nancy Klauber‐DeMore, Lee K. Tan, Laura Liberman, Annals of Surgical Oncology Surgical OncologyCancer DetectionMedicineHistopathologyPathology	2000	306
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study Anita Mamtani, Andrea V. Barrio, Tari A. King, Annals of Surgical Oncology Surgical OncologyMedicineCancer ManagementSurgical PathologyBreast Cancer	2016	303
Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures Hiram S. Cody, Jane V. Fey, Tim Akhurst, Annals of Surgical Oncology Blue DyeStain NormalizationBreast OncologyMedicineBreast Imaging	2001	251

Page 1